Colin M. Adams
On June 4, 2026, Colin M. Adams, Esq. was elected as a director of the Board of the Company, effective immediately.
Highest-materiality recent filing
Sleep Number receives Nasdaq delisting notice after Chapter 11 filing; trading suspended June 23
Nasdaq delisting based on Chapter 11 filing, public interest concerns, and residual equity worries.
Sleep Number enters DIP financing up to $260M in Chapter 11; maturity Sept 16, 2026
$65M new money term loans plus $195M roll-up of prepetition debt.
Sleep Number files Chapter 11; agrees to $415M sale to Sleep Country Canada subsidiary
Filed Chapter 11 on June 12, 2026; Stalking Horse Purchase Agreement with SNBR, Inc. (Sleep Country Canada) for $415M cash.
CEO Linda Findley receives $2.5M retention award, net $1.875M after waiving $625K sign-on bonus.
Sleep Number Q1 net sales $319M (-19% YoY); net loss widens to $50M
Net loss of $50.3M vs $9.3M loss in prior year; adjusted EBITDA $6.0M, down 74%.
Sleep Number enters forbearance agreement, adds $25M term loan at SOFR+8% with covenant relief
New $25M term loan at one-month SOFR + 8%, matures June 30, 2026; $5M amortization due June 1.
Sleep Number FY2025 net sales $1.4B, net loss $132M; guides double-digit EBITDA growth in 2026
Q4 net sales $347M (-8% YoY); net loss $59M vs $5M loss last year, including $47.9M deferred tax adjustment.
Sleep Number unveils turnaround plan, $50M cost actions, targets FCF in 2026
Strategy 'Sleep Number Shifts' focuses on product simplification, marketing modernization, and distribution expansion.
Sleep Number signs 3-year brand deal with Travis Kelce; Kelce to become top shareholder under 5%
Travis Kelce will be featured in Sleep Number national ad campaigns, including TV and digital content.
Sleep Number appoints Amy O'Keefe as CFO; reaffirms FY2025 guidance
Amy O'Keefe becomes CFO effective Dec 8, 2025, succeeding interim CFO Bob Ryder who advises through Dec 12.
Sleep Number discloses revised credit covenants; expects FY25 adjusted EBITDA ~$70M
Net leverage ratio covenant set at 5.25x for Q3 2025, stepping down to 4.00x by mid-2026.
Sleep Number Q3 net loss $40M, sales -19.6%; cuts FY2025 outlook, amends bank deal to 2027
Q3 net sales $343M, down 19.6% YoY; net loss $40M ($1.73/share) vs loss $3M last year.
Sleep Number amends credit facility with tighter covenants, extends maturity; director departs
Revolver reduced from $485M to $475M (further to $465M Jul 2026); accordion terminated.
Sleep Number Q2 net sales down 19.7% to $328M, net loss $25M; raises cost savings target to $130M
Net sales $328M, down 19.7% YoY; net loss $25M ($1.09/sh) vs loss $5M last year
Sleep Number appoints Bob Ryder interim CFO; Francis Lee steps down effective July 21, 2025
Francis Lee stepped down as CFO and principal accounting officer; will advise through Aug 15, 2025.
Sleep Number Q1 revenue falls 16% to $393M, net loss widens to $8.6M, launches restructuring
Net sales $393M, down 16% YoY; gross margin up 250bps to 61.2%.
Original $10M inducement grant restructured to 724,114 shares at $13.81 (2024 average closing price) due to post-earnings stock decline.
Sleep Number settles with Stadium Capital; five directors to leave board
Stadium Capital, largest shareholder, withdraws director nominations under agreement.
Sleep Number Q4 net loss narrows to $5M; appoints Linda Findley CEO
Q4 net sales $377M (-12% YoY); gross margin 59.9% (+330 bps); net loss $5M (vs -$25M prior year).
Sleep Number appoints Linda Findley as President and CEO effective April 7, 2025
Linda Findley, former Blue Apron CEO and Etsy COO, succeeds retiring Shelly Ibach as CEO and joins Board.
Sleep Number rejects Stadium Capital's demand to join CEO successor committee
Board added two directors recommended by Stadium last November; has engaged extensively over past year.
Sleep Number Q3 sales down 10% to $427M; CEO Ibach to retire
Net sales of $427M, down 10% YoY; gross margin 60.8% (+340 bps YoY).
Sleep Number CEO Shelly Ibach to retire by 2025 annual meeting; board to declassify
Shelly Ibach to retire as CEO no later than May 2025; will remain Chair through annual meeting then serve as strategic advisor.
Sleep Number Q2 net sales fell 11% to $408M; adjusted EBITDA $28M, down from $35M last year
Net sales $408M, down 11% YoY; order backlog changes pressured sales by ~6 percentage points.
Sleep Number Q1 net sales down 11% to $470M; adjusted EBITDA $37M slightly ahead of outlook
Net sales $470M, down 11% YoY including ~4 ppt pressure from order backlog changes.
Sleep Number reports Q4 net sales down 14% to $430M; full year loss per share $0.68
Q4 net sales $430M, down 14% YoY; demand down low-single digits; gross margin improved 190 bps to 56.6%.
Sleep Number Q3 net sales down 13%, loss $0.10; restructures with 500 job cuts, store closures
Q3 net sales $473M (-13% YoY); diluted loss per share of $0.10 vs $0.22 EPS last year.
Sleep Number adds 2 directors, forms capital committee in pact with Stadium Capital
Appointed Stephen Macadam (ex-EnPro CEO) and Hilary Schneider (ex-Shutterfly CEO) to expanded 12-member board.
Sleep Number offers activist Stadium Capital input on new independent director
Sleep Number responds to Stadium Capital's press release; Board has engaged in regular discussions.
Sleep Number appoints Francis Lee as EVP and CFO effective Aug 14, 2023
Francis Lee appointed EVP & CFO effective Aug 14; interim CFO Krusmark returns to CHRO role.
Sleep Number Q2 EPS $0.03 vs $1.54; sales down 16%; appoints Francis Lee CFO
Q2 net sales $459M (-16% YoY); diluted EPS $0.03 vs $1.54 prior year.
On June 4, 2026, Colin M. Adams, Esq. was elected as a director of the Board of the Company, effective immediately.
Effective June 6, 2025, Francis Lee, Chief Financial Officer, will serve as the Company’s principal accounting officer.
On May 23, 2025, Joel Laing, Vice President, Treasurer and Chief Accounting Officer of Sleep Number Corporation (the “Company”), who serves as the Company’s principal accounting officer, provided notice that he will resign from the Company, effective June 5, 2025.
the role then held by Annie Bloomquist , Executive Vice President and Chief Innovation Officer was eliminated and she ceased serving in that role
On March 5, 2025, Sleep Number Corporation (the “Company”) announced that the Board of Directors unanimously appointed Linda Findley to the position of President and Chief Executive Officer and Board member, effective as of April 7, 2025.
Ms. Matas informed the Company that she will not stand for re-election to the Board when her term expires at the conclusion of the 2025 Annual Meeting.
Mr. Harrison informed the Company that he will not stand for re-election to the Board when his term expires at the conclusion of the 2025 Annual Meeting.
Mr. Gulis, agreed to retire or resign from the Board no later than the completion of the Company’s debt refinancing or at the conclusion of the 2026 Annual Meeting, whichever occurs first.
Ms. Lauderback agreed to retire or resign from the Board effective December 31, 2025.
Shelly R. Ibach, Chair, President and Chief Executive Officer of Sleep Number Corporation (the “Company”), informed the Company’s Board of Directors that she will retire from the Company and Board no later than the 2025 Annual Meeting of Shareholders (the “2025 Annual Meeting”).
the Board increased the size of the Board to twelve (12) directors and appointed Hilary Schneider and Stephen Macadam to the Board
the Board increased the size of the Board to twelve (12) directors and appointed Hilary Schneider and Stephen Macadam to the Board
Max materiality 1.00 · Median 0.60 · Most common event other_material